Skip to main content
Toggle navigation
Login
Home
Session Icons
Special Event
Livestream / Recorded
Multiple Session Occurences
Audience Response System
Ticketed Session
Presentado en Espanol
Closed Captioning
Scientific Program
Sold Out Ticketed Session
New & Evolving Topics
Traduccion Espanol
Rx (Pharmacology)
Poster Icons
Oral Presentations
Poster Presentations
Back
Favorite
Richard Lowenthal, MSEL
Chief Executive Officer
ARS
Abstract(s):
P4.A002: Comparative Stability of Three Epinephrine Products Under Extreme Temperature Conditions
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT
P4.A010: Pediatric doses of neffy (intranasal nasal spray) demonstrate pharmacokinetic profiles that are equivalent to epinephrine injections products
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT
P4.A017: neffy, nasal epinephrine sprayer, demonstrated successful use by patients and caregivers: Human Factor Findings
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT